Skip to main content

Publisher: Bentham Science Publishers

More about this publication?
Volume 14, Number 5, 2014

Articles

Single-Stranded γPNAs for In Vivo Site-Specific Genome Editing via Watson-Crick Recognition
pp. 331-342(12)
Authors: Bahal, Raman; Quijano, Elias; A. McNeer, Nicole; Liu, Yanfeng; C. Bhunia, Dinesh; Lopez-Giraldez, Francesco; J. Fields, Rachel; M. Saltzman, William; H. Ly, Danith; M. Glazer, Peter

Favourites:
ADD

Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
pp. 343-351(9)
Authors: Xu, Hong; W. Rosler, Thomas; Carlsson, Thomas; de Andrade, Anderson; Fiala, Ondrej; Hollerhage, Matthias; H. Oertel, Wolfgang; Goedert, Michel; Aigner, Achim; U. Hoglinger, Gunter

Favourites:
ADD

Integrase-Deficient Lentivirus: Opportunities and Challenges for Human Gene Therapy
pp. 352-364(13)
Authors: Liu, Kuan-Can; Lin, Bao-Shun; Gao, An-Ding; Ma, Hong-Yu; Zhao, Meng; Zhang, Rui; Yan, Hui-Hui; Yi, Xun-Fei; Lin, Si-Jie; Que, Jian-Wen; Lan, Xiao-Peng

Favourites:
ADD

Codon Swapping of Zinc Finger Nucleases Confers Expression in Primary Cells and In Vivo from a Single Lentiviral Vector
pp. 365-376(12)
Authors: Cecilia, Abarrategui-Pontes; Alison, Creneguy; Reynald, Thinard; Eli J., Fine; Virginie, Thepenier; Le Ray Laure, Fournier; Thomas J., Cradick; Gang, Bao; Laurent, Tesson; Guillaume, Podevin; Ignacio, Anegon; T. Huy, Nguyen

Favourites:
ADD

Reversal of Bone Cancer Pain by HSV-1-Mediated Silencing of CNTF in an Afferent Area of the Spinal Cord Associated with AKT-ERK Signal Inhibition
pp. 377-388(12)
Authors: Yang, Xu; Liu, Jia; Liu, Zun-Jing; Xia, Qing-Jie; He, Mu; Liu, Ran; Liu, Wei; Wang, Wei; Liu, Jin; Zhou, Xin-Fu; Zhang, Yun-Hui; Wang, Ting-Hua

Favourites:
ADD

Identification of Vβ7.1_H3F7 as a Therapeutic Gene Encoding TCR Specific to Hepatocellular Carcinoma
pp. 389-399(11)
Authors: Huang, Shulin; Shen, Han; Li, Zhiming; Chiu, Sung-Kay; Ruan, Runsheng; Xiao, Lanfeng; Tzeng, Chi-Meng

Favourites:
ADD

SALL4: Engine of Cell Stemness
pp. 400-411(12)
Author: Xiong, Jianhua

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content